Novo Nordisk issues statement on illegal mass compounding and
Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 -
Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an
unapproved, inauthentic, and untested knockoff semaglutide pill.